Fukuoka, Japan

Yoshinori Katakura

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshinori Katakura: Innovator in Disease Risk Assessment

Introduction

Yoshinori Katakura is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of health technology, particularly in the assessment of disease risks. His innovative work focuses on dementia prevention, showcasing his commitment to improving public health.

Latest Patents

Yoshinori Katakura holds a patent for a "Disease risk assessment apparatus, disease risk assessment method, computer readable medium, and food for dementia prevention." This apparatus assesses the risk of developing dementia in a subject by analyzing the concentration of specific amino acids in the subject's blood. The amino acids involved include histidine, phenylalanine, leucine, isoleucine, methionine, threonine, glycine, glutamine, lysine, asparagine, homocysteine, cystathionine, S-adenosylmethionine, and S-adenosylhomocysteine. This innovative approach has the potential to revolutionize how we understand and mitigate the risks associated with dementia.

Career Highlights

Throughout his career, Yoshinori Katakura has worked with esteemed institutions such as Kyushu University and Kurume Research Park Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in health technology.

Collaborations

Yoshinori has collaborated with notable colleagues, including Toshiharu Ninomiya and Satoru Kuhara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Yoshinori Katakura's contributions to disease risk assessment highlight his dedication to improving health outcomes. His innovative patent serves as a testament to his expertise and commitment to addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…